Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Login and Edit functionaility are currrently unavailable.

Search Result Details

This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to Mulligan, Richard
Item TypeName
Mentoring - Completed Student Project A Gene therapy Approach Towards Blocking EPHRIN-B2/EPH-B4 Vascular Interactions in Tumor Angiogenesis
Academic Article Gene therapy of prostate cancer with the soluble vascular endothelial growth factor receptor Flk1.
Academic Article Gene therapy for pancreatic cancer.
Academic Article Gene therapy to target dendritic cells from blood to lymph nodes.
Academic Article Gene therapy for Wiskott-Aldrich syndrome: rescue of T-cell signaling and amelioration of colitis upon transplantation of retrovirally transduced hematopoietic stem cells in mice.
Academic Article Advanced renal cell carcinoma treated with granulocyte-macrophage colony-stimulating factor gene therapy: a clinical course of the first Japanese experience.
Academic Article The molecular biology of Gaucher disease and the potential for gene therapy.
Academic Article Gene therapy of metastatic cancer by in vivo retroviral gene targeting.
Academic Article Demonstration of a rational strategy for human prostate cancer gene therapy.
Academic Article A phase I trial of adeno-associated virus serotype 1-?-sarcoglycan gene therapy for limb girdle muscular dystrophy type 2C.
Academic Article The basic science of gene therapy.
Grant Improving the Safety Profile of Lentiviral Vectors
Grant CORE--PILOT AND FEASIBILITY STUDIES
Grant GENE TRANSFER PROGRAM IN HEART, LUNG, AND BLOOD DISEASE
Grant STEM CELL THERAPY OF CONGENITAL DEFECTS IN HEMATOPOIESIS
Grant Engineered in vivo nuclear fusion: application to regenerative medicine
Grant GENE THERAPY FOR CANCER--GENETICALLY MODIFIED CELLS
Search Criteria
  • Gene Therapy
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.